Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation Research. 1989;65:640-646

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lafferty, H. M.
Right arrow Articles by Anderson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lafferty, H. M.
Right arrow Articles by Anderson, S.

Circulation Research, Vol 65, 640-646, Copyright © 1989 by American Heart Association

ARTICLES

Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass

HM Lafferty, M Gunning, P Silva, MB Zimmerman, BM Brenner and S Anderson
Renal Division, Brigham and Women's Hospital, Boston, MA 02115.

To investigate the in vivo effects of inhibition of endopeptidase 24.11, an enkephalinase enzyme shown to be involved in atrial natriuretic peptide (ANP) breakdown in vitro, we infused phosphoramidon, a specific inhibitor of endopeptidase 24.11, into rats with reduced renal mass (and chronic extracellular volume expansion) and into normal rats. Relative to baseline values in rats with remnant kidneys, phosphoramidon led to elevations of plasma ANP levels and concomitant increases in urinary sodium excretion, fractional excretion of sodium, glomerular filtration rate, filtration fraction, and urinary cyclic GMP excretion. Similar changes in renal function and urinary cyclic GMP excretion were obtained with thiorphan, another endopeptidase 24.11 inhibitor. These enhanced ANP levels and renal actions were not observed with phosphoramidon in normal rats. These results show that plasma ANP levels can be modulated in rats with reduced renal mass by inhibition of endopeptidase 24.11.


This article has been cited by other articles:


Home page
 Exp PhysiolHome page
R. M. Chamberlain and D. G. Shirley
Renal: Time course of the renal functional response to partial nephrectomy: measurements in conscious rats
Exp Physiol, January 1, 2007; 92(1): 251 - 262.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Abe, Y. Arakawa, A. K. Rajasekaran, T.-H. Yu, and O. Wada
Interaction of Atrial Natriuretic Peptide with Its Receptors in Bovine Lung Membranes
J. Biol. Chem., March 31, 1995; 270(13): 7672 - 7678.
[Abstract] [Full Text] [PDF]


Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.